-Matthew P Goetz Researcher Activity Profile

Research Author Detailed Information 

Matthew P Goetz Publication Rate By Year

Matthew P Goetz has published 9 paper(s) in 2007, for a total of 9 research publications in total.

Matthew P Mp Goetz Author Information

LAST NAME: goetz

FIRST NAME: Matthew P

INITIALS: mp

AFFILIATION:

Papers

Matthew P Goetz's Publication Record

1. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Year Published: 2007
Department of Oncology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN , 55905, USA, goetz.matthew@mayo.edu.
2. Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer. Year Published: 2007
Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN 55905, USA. mcwilliams.robert@mayo.edu
3. Aromatase inhibitors and tamoxifen: where do we go from here? Year Published: 2007
Mayo Clinic College of Medicine, Rochester, MN 55905, USA. goetz.matthew@mayo.edu
4. Early discontinuation of tamoxifen: a lesson for oncologists. Year Published: 2007
Department of Oncology, Mayo Clinic, College of Medicine, Rochester, Minnesota.
5. Early discontinuation of tamoxifen: a lesson for oncologists. Year Published: 2007
6. Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response. Year Published: 2007
1Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
7. Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response. Year Published: 2007
Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. goetz.matthew@mayo.edu
8. Early discontinuation of tamoxifen: a lesson for oncologists. Year Published: 2007
9. Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response. Year Published: 2007
Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. goetz.matthew@mayo.edu